Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 17, 2018
RXTransparent has been awarded a contract with Minnesota Multistate Contracting Alliance for Pharmacy for FDA DSCSA Compliance Solutions.
read more
Monday, September 17, 2018
Samumed has entered an exclusive license agreement with United Therapeutics for North American rights to Samumed's SM04646, being developed for the treatment of idiopathic pulmonary fibrosis.
read more
Monday, September 17, 2018
PAREXEL and Datavant announced they are partnering to enhance clinical study design and operations, as well as the generation of real-world evidence.
read more
Friday, September 14, 2018
Nephron Pharmaceuticals is currently producing medications at its West Columbia, S.C. facility while monitoring the effects of Hurricane Florence.
read more
Friday, September 14, 2018
Natera announced an agreement with Bristol-Myers Squibb to use Natera's Signatera custom circulating tumor DNA assay in a Phase 2 study in the adjuvant non-small cell lung cancer setting.
read more
Thursday, September 13, 2018
Cambrex has completed the acquisition of Halo Pharma, a dosage form CDMO located in Whippany, New Jersey and Mirabel, Québec, Canada, for approximately $425 million.
read more
Thursday, September 13, 2018
CytRx has received a milestone payment of $250,000 from Orphazyme A/S.
read more
Thursday, September 13, 2018
Particle Sciences has announced the appointment of Dr. Robert Lee to president.
read more
Thursday, September 13, 2018
Mitra Biotech announced a partnership with Glenmark Pharmaceuticals focused on advancing Glenmark's proprietary immuno-oncology drug pipeline utilizing Mitra's CANscript platform.
read more
Wednesday, September 12, 2018
Pelican BioThermal announces the opening of a new network station & service center in Indianapolis.
read more
Wednesday, September 12, 2018
The FDA has announced the availability of a draft guidance for industry that is applicable to holders of approved new drug applications, ANDAs, new animal drug applications, abbreviated new animal drug applications and holders of drug master files ...
read more
Wednesday, September 12, 2018
Amneal has received FDA approval on its ANDA for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg and 200 mg and has immediately initiated commercialization activities.
read more
Wednesday, September 12, 2018
PAREXEL announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, ...
read more
Wednesday, September 12, 2018
Simulations Plus has received notice from the FDA that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two years, to integrate drug product quality attributes into the mechanistic TCAT model in GastroPlus.
read more
Tuesday, September 11, 2018
Maravai LifeSciences announced plans to relocate and expand its TriLink BioTechnologies operations with the signing of a lease on a new facility in the Sorrento Valley area of San Diego.
read more